Maternal and Child Health Journal

, Volume 17, Issue 7, pp 1191–1198 | Cite as

Maternal and Fetal Outcomes After Introduction of Magnesium Sulphate for Treatment of Preeclampsia and Eclampsia in Selected Secondary Facilities: A Low-Cost Intervention

  • Jamilu Tukur
  • Babatunde Ahonsi
  • Salisu Mohammed Ishaku
  • Idowu Araoyinbo
  • Ekechi Okereke
  • Ayodeji Oginni Babatunde
Article

Abstract

The aim of this study was to evaluate whether a new low-cost strategy for the introduction of magnesium sulphate (MgSO4) for preeclampsia and eclampsia in low-resource areas will result in improved maternal and perinatal outcomes. Doctors and midwives from ten hospitals in Kano, Nigeria, were trained on the use of MgSO4. The trained health workers later conducted step-down trainings at their health facilities. MgSO4, treatment protocol, patella hammer, and calcium gluconate were then supplied to the hospitals. Data was collected through structured data forms. The data was analyzed using SPSS software. From February 2008 to January 2009, 1,045 patients with severe preeclampsia and eclampsia were treated. The case fatality rate for severe preeclampsia and eclampsia fell from 20.9 % (95 % CI 18.7–23.2) to 2.3 % (95 % CI 1.5–3.5). The perinatal mortality rate was 12.3 % as compared to 35.3 % in a center using diazepam. Introduction of MgSO4 in low-resource settings led to improved maternal and fetal outcomes in patients presenting with severe pre-eclampsia and eclampsia. Training of health workers on updated evidence-based interventions and providing an enabling environment for their practice are important components to the attainment of the Millenium Development Goals (MDG) in developing countries.

Keywords

Severe preeclampsia Eclampsia Maternal mortality Millennium development goals Magnesium sulphate 

References

  1. 1.
    United Nations. Millennium Development Goals. 2007 progress report 2007, http://mdgs.un.org/unsd/mdg/default.aspx. Accessed January 2011.
  2. 2.
    Duley, L. (2009). The global impact of pre-eclampsia and eclampsia. Seminars in Perinatology, 33(3), 130–137.PubMedCrossRefGoogle Scholar
  3. 3.
    Khan, K. S., Wojdyla, D., Say, L., et al. (2006). WHO analysis of causes of maternal death: A systematic review. Lancet, 367, 1066–1074.PubMedCrossRefGoogle Scholar
  4. 4.
    The Eclampsia Trial Collaborative Group. (1995). Which anticonvulsant for women with eclampsia? Evidence from the collaborative eclampsia trial. Lancet, 345(8963), 1455–1463.Google Scholar
  5. 5.
    Tukur, J. (2009). The use of magnesium sulphate for the treatment of severe pre-eclampsia and eclampsia. Annals of African Medicine, 8, 76–80.PubMedCrossRefGoogle Scholar
  6. 6.
    Langer, A., Viller, J., Tell, K., Kim, T., & Kennedy, S. (2008). Reducing eclampsia related deaths: A call to action. Lancet, 371, 705–706.PubMedCrossRefGoogle Scholar
  7. 7.
    Ridge, L. A., Bero, L. A., & Hill, R. S. (2010). Identifying barriers to the availability and use of magnesium sulphate injection in resource poor countries: A case study in Zambia. BioMedical Central Health Services Research, 10, 340.CrossRefGoogle Scholar
  8. 8.
    Sheith, S. S., & Chalmers, I. (2002). Magnesium for preventing and treating eclampsia: Time for international action. Lancet, 359, 1872–1873.CrossRefGoogle Scholar
  9. 9.
    National Population Commission. (2006). Population and housing census of the Federal Republic of Nigeria. Available from http://www.population.gov.ng/images/stories/Priority%20Tables%20Volume%20I-update.pdf (Accessed July 14th 2011).
  10. 10.
    National Population Commission (NPC) and ICF Macro. (2008). Nigeria Demographic and Health Survey (NDHS). http://www.measuredhs.com/pubs/pdf/GF15/GF15.pdf.
  11. 11.
    Kombe, G., Fleisher, L., Kariisa, E., Arur, A., Sanjana, P., & Paina, L. et al. (April 2009). Nigeria health system assessment 2008. Abt Associates Inc.Google Scholar
  12. 12.
    Adamu, Y. M., Salihu, H. M., Sathiakumar, N., & Alexander, R. (2003). Maternal mortality in Northern Nigeria: A population based study. European Journal of Obstetrics, Gynaecology and Reproductive Biology, 109(2), 153–159.CrossRefGoogle Scholar
  13. 13.
    Kullima, A. A., Kawuwa, M. B., Audu, B. M., Usman, H., & Geidam, A. D. (2009). A 5-year review of maternal mortality associated with eclampsia in a tertiary institution in northern Nigeria. Annals of African Medicine, 8(2), 81–84.PubMedCrossRefGoogle Scholar
  14. 14.
    Tukur, J., Umar, B. A., & Rabi’u, A. (2007). Pattern of eclampsia in a tertiary health facility situated at a semi rural town in Northern Nigeria. Annals of African Medicine, 6(4), 164–167.PubMedCrossRefGoogle Scholar
  15. 15.
    Onakewhor, J. U., & Gharoro, E. P. (2008). Changing trends in maternal mortality in a developing country. Nigerian Journal of Clinical Practice, 11(2), 111–120.PubMedGoogle Scholar
  16. 16.
    Eke, A. C., Ezebialu, U. I., & Okafor, C. (2011). Presentation and outcome of eclampsia at a tertiary center in South East Nigeria—A 6-year review. Hypertension in Pregnancy, 30, 125–132.PubMedCrossRefGoogle Scholar
  17. 17.
    Tsu, V. D., & Shane, B. (2004). New and underutilized technologies to reduce maternal mortality: Call to action from a bellagio workshop. International Journal of Gynaecology and Obstetrics, 85(Suppl 1), S83–S93.PubMedCrossRefGoogle Scholar
  18. 18.
    Firoz, T. et al. (2011). Pre-eclampsia in low and middle income countries. Best Practice & Research Clinical Obstetrics and Gynaecology. doi:10.1016/j.bpobgyn.2011.04.002.
  19. 19.
    Goldenberg, R. L., McClure, E. M., McGuire, E. R., Kamath, B. D., & Jobe, H. A. (2011). Lessons for low-income regions following the reduction in hypertension-related maternal mortality in high-income countries. International Journal of Gynaecology and Obstetrics, 113, 91–95.PubMedCrossRefGoogle Scholar
  20. 20.
    Askie, L., Duley, L., Henderson-Smart, D., et al. (2007). Antiplatelet agents for prevention of pre-eclampsia: A meta-analysis of individual patient data. Lancet, 369, 1791–1798.PubMedCrossRefGoogle Scholar
  21. 21.
    Hofmeyr, G. J., Atallah, A. N., & Duley, L. (2006). Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems. Cochrane Database of Systematic Reviews, CD001059.Google Scholar
  22. 22.
    Melah, G. S., Massah, A. A., & El Nafaty, A. U. (2006). Pregnancy outcomes of women with eclampsia in Gombe, Nigeria. International Journal of Gynecology and Obstetrics, 92, 251–252.PubMedCrossRefGoogle Scholar
  23. 23.
    Jabeen, M., Yakoob, M. Y., Imdad, A., & Bhutta, Z. A. (2011). Impact of interventions to prevent and manage preeclampsia and eclampsia on stillbirths. BioMed Central Public Health, 11(Suppl 3), S6.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2012

Authors and Affiliations

  • Jamilu Tukur
    • 1
  • Babatunde Ahonsi
    • 2
  • Salisu Mohammed Ishaku
    • 2
  • Idowu Araoyinbo
    • 2
  • Ekechi Okereke
    • 2
  • Ayodeji Oginni Babatunde
    • 2
  1. 1.Department of Obstetrics and GynaecologyBayero University/Aminu Kano Teaching HospitalKanoNigeria
  2. 2.Population CouncilAbujaNigeria

Personalised recommendations